Total Payments
$94,769
2024 Payments
$22,372
Companies
22
Transactions
220
Medicare Patients
12,267
Medicare Billing
$4.2M
Payment Breakdown by Category
Other$53,703 (56.7%)
Consulting$29,246 (30.9%)
Food & Beverage$7,877 (8.3%)
Travel$3,863 (4.1%)
Education$79.92 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,250 | 17 | 53.0% |
| Consulting Fee | $29,246 | 14 | 30.9% |
| Food and Beverage | $7,877 | 172 | 8.3% |
| Travel and Lodging | $3,863 | 13 | 4.1% |
| Honoraria | $3,453 | 3 | 3.6% |
| Education | $79.92 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $37,200 | 37 | $0 (2024) |
| Allergan, Inc. | $20,205 | 45 | $0 (2021) |
| EyePoint Pharmaceuticals US, Inc. | $17,105 | 28 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $6,131 | 10 | $0 (2024) |
| Alimera Sciences, Inc. | $4,279 | 16 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $2,317 | 4 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,741 | 6 | $0 (2021) |
| Genentech USA, Inc. | $1,550 | 23 | $0 (2024) |
| Alcon Laboratories Inc | $1,349 | 4 | $0 (2017) |
| Alcon Vision LLC | $737.58 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,372 | 47 | ABBVIE INC. ($16,951) |
| 2023 | $22,602 | 33 | EyePoint Pharmaceuticals US, Inc. ($10,221) |
| 2022 | $21,493 | 42 | ABBVIE INC. ($10,752) |
| 2021 | $21,658 | 43 | Allergan, Inc. ($19,795) |
| 2020 | $2,612 | 10 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,615) |
| 2019 | $1,019 | 24 | Alcon Vision LLC ($295.99) |
| 2018 | $771.92 | 10 | Alimera Sciences, Inc. ($319.00) |
| 2017 | $2,242 | 11 | Alcon Laboratories Inc ($1,349) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug) | Honoraria | Cash or cash equivalent | $1,312.50 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/16/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: EYE CARE | ||||||
| 12/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: EYE CARE | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | SURGICAL MISC (Device) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: EYE CARE | ||||||
| 11/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $149.71 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/08/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $113.00 | General |
| 10/18/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $41.33 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: EYE CARE | ||||||
| 09/23/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $39.85 | General |
| 09/18/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $38.70 | General |
| 09/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: EYE CARE | ||||||
| 09/12/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Biological | ||||||
| 08/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: EYE CARE | ||||||
| 07/30/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/16/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,337 | 13,384 | $5.3M | $1.2M |
| 2022 | 17 | 3,462 | 8,317 | $4.0M | $1.2M |
| 2021 | 18 | 3,020 | 7,431 | $2.7M | $1.0M |
| 2020 | 19 | 2,448 | 5,728 | $1.5M | $760,530 |
Total Patients
12,267
Total Services
34,860
Medicare Billing
$4.2M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 102 | 766 | $1.9M | $530,806 | 27.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 823 | 1,825 | $667,950 | $191,159 | 28.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 22 | 5,520 | $690,000 | $161,389 | 23.4% |
| J7314 | Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg | Office | 2023 | 11 | 234 | $325,000 | $96,606 | 29.7% |
| 92134 | Imaging of retina | Office | 2023 | 869 | 1,900 | $855,000 | $66,549 | 7.8% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 27 | 392 | $168,168 | $62,194 | 37.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 157 | 531 | $303,123 | $55,706 | 18.4% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 701 | 1,488 | $171,120 | $19,566 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $46,530 | $13,914 | 29.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 14 | 15 | $37,695 | $12,001 | 31.8% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 38 | 43 | $32,379 | $10,066 | 31.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 63 | 81 | $30,213 | $9,015 | 29.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 291 | 356 | $44,500 | $7,433 | 16.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 51 | 51 | $21,981 | $5,587 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $6,878 | $1,988 | 28.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 22 | 31 | $8,153 | $1,304 | 16.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 13 | 17 | $4,403 | $1,114 | 25.3% |
| 92250 | Photography of the retina | Office | 2023 | 15 | 16 | $3,104 | $555.49 | 17.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 110 | 938 | $1.8M | $669,905 | 36.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 746 | 1,657 | $490,552 | $181,230 | 36.9% |
| 92134 | Imaging of retina | Office | 2022 | 883 | 2,041 | $602,750 | $72,546 | 12.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 31 | 413 | $204,372 | $64,256 | 31.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 168 | 585 | $331,789 | $61,825 | 18.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 16 | 212 | $152,600 | $48,336 | 31.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 686 | 1,511 | $129,269 | $20,467 | 15.8% |
About Dr. Brian Do, M.D
Dr. Brian Do, M.D is a Ophthalmology healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1073807681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Do, M.D has received a total of $94,769 in payments from pharmaceutical and medical device companies, with $22,372 received in 2024. These payments were reported across 220 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($50,250).
As a Medicare-enrolled provider, Do has provided services to 12,267 Medicare beneficiaries, totaling 34,860 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Uveitis and Ocular Inflammatory Disease
- Location Chevy Chase, MD
- Active Since 06/01/2011
- Last Updated 06/15/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1073807681
Products in Payments
- OZURDEX (Drug) $54,864
- YUTIQ (Drug) $18,529
- XIPERE (Drug) $4,300
- ILUVIEN (Drug) $2,401
- Vabysmo (Drug) $1,055
- SURGICAL MISC (Device) $800.00
- Constellation (Device) $548.72
- STELLARIS PC (Device) $414.90
- ACTHAR (Biological) $271.59
- EYLEA AFLIBERCEPT INJECTION (Biological) $201.23
- EYLEA HD (Biological) $200.72
- AcrySof (Device) $182.75
- Lucentis (Biological) $175.48
- Izervay (Drug) $167.49
- NGENUITY (Device) $156.03
- INVELTYS (Drug) $124.80
- XIIDRA (Drug) $122.76
- DEXYCU (Drug) $118.83
- BEOVU (Drug) $112.22
- SUSVIMO (Drug) $107.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Chevy Chase
Thomas Clinch, Md, MD
Ophthalmology — Payments: $248,965
Ophthalmology $248,965
Dr. Anand Mantravadi, M.d, M.D
Ophthalmology — Payments: $135,695
Ophthalmology $135,695
Dr. Hylton Mayer, M. D, M. D
Ophthalmology — Payments: $96,221
Ophthalmology $96,221
Neil Martin, Md, MD
Ophthalmology — Payments: $13,932
Ophthalmology $13,932
Dr. Kenneth Schor, M.d, M.D
Ophthalmology — Payments: $13,226
Ophthalmology $13,226
Dr. Michael Lai, Md, MD
Ophthalmology — Payments: $12,898
Ophthalmology $12,898